3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
2
Genitourinary
1
Gastrointestinal
1
Classical hematology
1
Breast
1
Conditions
Venous Thromboembolism
1
Urologic Neoplasms
1
Urogenital Neoplasms
1
Thrombosis
1
Thromboembolism
1
Prostatic Neoplasms
1
Neoplasms
1
Lung Neoplasms
1
Inflammation
1
Immune System Diseases
1
Colonic Neoplasms
1
Cardiovascular Diseases
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Interventions
pembrolizumab
26
Magnetic Resonance Spectroscopy
14
Nivolumab
13
Docetaxel
13
Specimen Handling
11
Radiotherapy
9
Paclitaxel
9
Radiosurgery
8
Early Intervention, Educational
8
Cyclophosphamide
8
Gemcitabine
7
atezolizumab
6
Taxes
6
Surveys and Questionnaires
6
Standard of Care
6
Psychiatric Rehabilitation
6
Ipilimumab
6
Carboplatin
6
sargramostim
5
Pemetrexed
5
Methods
5
motexafin gadolinium
4
fludarabine
4
X-Rays
4
Interviews as Topic
4
Immunoglobulin G
4
Fluorouracil
4
Educational Status
4
Cisplatin
4
Biopsy
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lung Neoplasms
×
Rivaroxaban
×
Genitourinary
×
Clear all
NCT06065592
2023-10-06
CAT_PB
Lebanese University
Phase 1
Unknown
500 enrolled